These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 25227983)
1. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia. Amirghofran Z; Asiaee E; Kamazani FM Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983 [TBL] [Abstract][Full Text] [Related]
2. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival. Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578 [TBL] [Abstract][Full Text] [Related]
3. Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6. Weg-Remers S; Hildebrandt U; Feifel G; Moser C; Zeitz M; Stallmach A Am J Gastroenterol; 1998 May; 93(5):790-4. PubMed ID: 9625129 [TBL] [Abstract][Full Text] [Related]
4. Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors. Ahmed MI; Hassab HM Egypt J Immunol; 2008; 15(2):101-11. PubMed ID: 20306693 [TBL] [Abstract][Full Text] [Related]
5. Serum soluble CD44 in pediatric patients with acute leukemia. Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M J Pediatr Hematol Oncol; 1999; 21(5):384-8. PubMed ID: 10524451 [TBL] [Abstract][Full Text] [Related]
6. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients. Mayer S; zur Hausen A; Watermann DO; Stamm S; Jäger M; Gitsch G; Stickeler E J Cancer Res Clin Oncol; 2008 Nov; 134(11):1229-35. PubMed ID: 18438684 [TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression. Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139 [TBL] [Abstract][Full Text] [Related]
8. The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer. Yoo CH; Noh SH Cancer Res Treat; 2003 Feb; 35(1):3-8. PubMed ID: 26680908 [TBL] [Abstract][Full Text] [Related]
9. Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes. Nasu H; Hibi N; Ohyashiki JH; Hara A; Kubono K; Tsukada Y; Ando K; Iwama H; Hayashi S; Yahata N; Toyama K; Ohyashiki K Int J Oncol; 1998 Sep; 13(3):525-30. PubMed ID: 9683788 [TBL] [Abstract][Full Text] [Related]
10. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma. Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541 [TBL] [Abstract][Full Text] [Related]
11. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia]. Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858 [TBL] [Abstract][Full Text] [Related]
13. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Afify A; Lynne LC; Howell L Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576 [TBL] [Abstract][Full Text] [Related]
14. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia]. Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427 [TBL] [Abstract][Full Text] [Related]
15. CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance. Kamazani FM; Bahoush GR; Aghaeipour M; Vaeli S; Amirghofran Z Med Oncol; 2013 Mar; 30(1):359. PubMed ID: 23263849 [TBL] [Abstract][Full Text] [Related]
16. Serological evaluation of soluble CD44 in renal cancer. Kan M; Kanayama H; Naruo S; Tsuji M; Kojima K; Kurokawa Y; Kagawa S Jpn J Cancer Res; 1996 Nov; 87(11):1191-4. PubMed ID: 9045950 [TBL] [Abstract][Full Text] [Related]
17. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Yamane N; Tsujitani S; Makino M; Maeta M; Kaibara N Oncology; 1999 Apr; 56(3):232-8. PubMed ID: 10202279 [TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma. Sasaki K; Niitsu N Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma. Lockhart MS; Waldner C; Mongini C; Gravisaco MJ; Casanova S; Alvarez E; Hajos S Oncol Rep; 1999; 6(5):1129-33. PubMed ID: 10425314 [TBL] [Abstract][Full Text] [Related]